Transforming growth factor-β controls T helper type 1 cell development through regulation of natural killer cell interferon-γ

被引:331
|
作者
Laouar, Y
Sutterwala, FS
Gorelik, L
Flavell, RA
机构
[1] Yale Univ, Sch Med, Immunobiol Sect, New Haven, CT 06520 USA
[2] Yale Univ, Sch Med, Infect Dis Sect, New Haven, CT 06520 USA
[3] Howard Hughes Med Inst, New Haven, CT 06520 USA
关键词
D O I
10.1038/ni1197
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Interferon-gamma and interleukin 12 produced by the innate arm of the immune system are important regulators of T helper type 1 (T(H)1) cell development, but signals that negatively regulate their expression remain controversial. Here we show that transforming growth factor-beta ( TGF-beta) controlled T(H)1 differentiation through the regulation of interferon-gamma produced by natural killer (NK) cells. Blockade of TGF-beta signaling in NK cells caused the accumulation of a large pool of NK cells secreting copious interferon-gamma, responsible for T(H)1 differentiation and protection from leishmania infection. In contrast, blockade of TGF-beta signaling in dendritic cells did not affect dendritic cell homeostasis or interleukin 12 production, thus indicating a previously undescribed demarcation of the function of TGF-beta in NK cells versus dendritic cells.
引用
收藏
页码:600 / 607
页数:8
相关论文
共 50 条
  • [31] Interferon-γ interferes with transforming growth factor-β signaling through direct interaction of YB-1 with Smad3
    Higashi, K
    Inagaki, Y
    Fujimori, K
    Nakao, A
    Kaneko, H
    Nakatsuka, I
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (44) : 43470 - 43479
  • [32] Mutation analysis of the transforming growth factor-β type II receptor in human cell lines resistant to growth inhibition by transforming growth factor-β
    F Vincent
    M Nagashima
    S Takenoshita
    M A Khan
    A Gemma
    K Hagiwara
    W P Bennett
    Oncogene, 1997, 15 : 117 - 122
  • [33] Innate immunity modulates autoimmunity:: type 1 interferon-β treatment in multiple sclerosis promotes growth and function of regulatory invariant natural killer T cells through dendritic cell maturation
    Gigli, Gianluigi
    Caielli, Simone
    Cutuli, Daniela
    Falcone, Marika
    IMMUNOLOGY, 2007, 122 (03) : 409 - 417
  • [34] Human BDCA3+Dendritic Cells as a Potent Interferon-λ Producer and an Enhancer of Helper T Cell and Natural Killer Cell Responsive to Hepatitis C Virus
    Yoshio, Sachiyo
    Kanto, Tatsuya
    Matsubara, Tokuhiro
    Sugiyama, Masaya
    Murata, Kazumoto
    Mizokami, Masashi
    Hayashi, Norio
    Takehara, Tetsuo
    HEPATOLOGY, 2013, 58 : 1180A - 1181A
  • [35] A porcine intrauterine 4-MDa component with transforming growth factor-β activity suppresses natural killer cell responses
    Segerson, EC
    Beetham, PK
    JOURNAL OF ANIMAL SCIENCE, 2000, 78 (07) : 1900 - 1906
  • [36] T cell death and transforming growth factor β1
    Golstein, P
    Wyllie, AH
    JOURNAL OF EXPERIMENTAL MEDICINE, 2001, 194 (04): : F19 - F21
  • [37] Interferon-γ inhibits the growth of human bronchial epithelial cells independently of transforming growth factor-β-1 and nitric oxide (NO)
    Kobayashi, M
    Niitsuma, T
    Hayashi, T
    Tanaka, M
    Takizawa, H
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1998, 244 (01) : 126 - 130
  • [38] Genotyping for polymorphisms in interferon-γ, interleukin-10, transforming growth factor-β1 and tumour necrosis factor-α genes:: a technical report
    Perrey, C
    Pravica, V
    Sinnott, PJ
    Hutchinson, IV
    TRANSPLANT IMMUNOLOGY, 1998, 6 (03) : 193 - 197
  • [39] Negative feedback regulation of T helper type 1 (Th1)/Th2 cytokine balance via dendritic cell and natural killer T cell interactions
    Minami, K
    Yanagawa, Y
    Iwabuchi, K
    Shinohara, N
    Harabayashi, T
    Nonomura, K
    Onoé, K
    BLOOD, 2005, 106 (05) : 1685 - 1693
  • [40] Immunomodulatory effects of interferon-β-1b in vivo:: induction of the expression of transforming growth factor-β1 and its receptor type II
    Ossege, LM
    Sindern, E
    Patzold, T
    Malin, JP
    JOURNAL OF NEUROIMMUNOLOGY, 1998, 91 (1-2) : 73 - 81